Kohala

W.S. Badger Company and Local Non-Profits Celebrate Hawai’i Island Ban on Toxic Sunscreens

Retrieved on: 
Monday, August 1, 2022

The new law, which goes into effect in Hawaii County on December 1, 2022, does not impact the sale of mineral sunscreens that contain zinc oxide or titanium dioxide.

Key Points: 
  • The new law, which goes into effect in Hawaii County on December 1, 2022, does not impact the sale of mineral sunscreens that contain zinc oxide or titanium dioxide.
  • Hawaii County follows Maui County in banning the sale of chemical (non-mineral) sunscreens except as prescribed by a licensed healthcare provider.
  • Maui County Councilmember Kelly Takaya King said: I am delighted that Hawaii Island has followed Maui Countys lead in protecting its coral reef and marine environment.
  • The Kohala Centers Kahaluu Bay Education Center (KBEC) on Hawaii Island educates the public about sunscreens and corals and swaps mineral sunscreens for chemical ones to protect the corals.

Four Seasons Resort Hualalai Welcomes Guests Back to Secluded Hawaii Island Destination on December 1, 2020

Retrieved on: 
Monday, November 9, 2020

Hualalai sits on over 800 acres of private, oceanfront property located on the esteemed Kona-Kohala coast of Hawaii Island.

Key Points: 
  • Hualalai sits on over 800 acres of private, oceanfront property located on the esteemed Kona-Kohala coast of Hawaii Island.
  • Four Seasons Resort Hualalai will reopen featuring Four Seasons new Lead With Care program.
  • The new program outlines clear procedures that educate and empower Four Seasons employees to take care of guests and each other.
  • Four Seasons Resort Hualalai has created exclusive andunique Hawaii Island experiencesdesigned for private, intimate groups.

Verrica Pharmaceuticals Announces Presentation of Positive Data from New Pooled Analysis of Phase 3 CAMP Trials of VP-102

Retrieved on: 
Saturday, January 18, 2020

Results from this analysis are being presented in a poster on January 18th-22nd at the 17th Annual Winter Clinical Dermatology Conference in Kohala Coast, Hawaii.

Key Points: 
  • Results from this analysis are being presented in a poster on January 18th-22nd at the 17th Annual Winter Clinical Dermatology Conference in Kohala Coast, Hawaii.
  • Efficacy was measured by the percentage of subjects with complete clearance of lesions in each location by visit.
  • Verrica intends to commence a Phase 3 program in the first quarter of 2020 to evaluate VP-102 for common warts.
  • VP-102 is also currently in a Phase 2 trial for the treatment of external genital warts.